PT2951292T - Plaquetas transfetadas por material genético exógeno e micropartículas de plaquetas obtidas pelas referidas plaquetas transfetadas, método para a preparação e utilizações das mesmas - Google Patents

Plaquetas transfetadas por material genético exógeno e micropartículas de plaquetas obtidas pelas referidas plaquetas transfetadas, método para a preparação e utilizações das mesmas

Info

Publication number
PT2951292T
PT2951292T PT147170823T PT14717082T PT2951292T PT 2951292 T PT2951292 T PT 2951292T PT 147170823 T PT147170823 T PT 147170823T PT 14717082 T PT14717082 T PT 14717082T PT 2951292 T PT2951292 T PT 2951292T
Authority
PT
Portugal
Prior art keywords
platelets
transfected
preparation
genetic material
exogenous genetic
Prior art date
Application number
PT147170823T
Other languages
English (en)
Original Assignee
Plasfer S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasfer S R L filed Critical Plasfer S R L
Publication of PT2951292T publication Critical patent/PT2951292T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/19Platelets; Megacaryocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091Purification or manufacturing processes for gene therapy compositions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0644Platelets; Megakaryocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/02Pentosyltransferases (2.4.2)
    • C12Y204/02008Hypoxanthine phosphoribosyltransferase (2.4.2.8)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Manufacturing & Machinery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT147170823T 2013-01-30 2014-01-30 Plaquetas transfetadas por material genético exógeno e micropartículas de plaquetas obtidas pelas referidas plaquetas transfetadas, método para a preparação e utilizações das mesmas PT2951292T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000054A ITRM20130054A1 (it) 2013-01-30 2013-01-30 Piastrine trasfettate con materiale genetico esogeno e microparticelle derivate da dette piastrine trasfettate, metodo per la loro preparazione e loro usi.

Publications (1)

Publication Number Publication Date
PT2951292T true PT2951292T (pt) 2021-08-30

Family

ID=47790357

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147170823T PT2951292T (pt) 2013-01-30 2014-01-30 Plaquetas transfetadas por material genético exógeno e micropartículas de plaquetas obtidas pelas referidas plaquetas transfetadas, método para a preparação e utilizações das mesmas

Country Status (10)

Country Link
US (3) US20150361453A1 (pt)
EP (1) EP2951292B1 (pt)
DK (1) DK2951292T3 (pt)
ES (1) ES2884727T3 (pt)
HU (1) HUE055345T2 (pt)
IT (1) ITRM20130054A1 (pt)
PL (1) PL2951292T3 (pt)
PT (1) PT2951292T (pt)
SI (1) SI2951292T1 (pt)
WO (1) WO2014118817A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200224164A1 (en) 2018-11-30 2020-07-16 Cellphire, Inc. Platelets as delivery agents
US20210180016A1 (en) * 2019-11-27 2021-06-17 Cellphire, Inc. PLATELETS LOADED WITH mRNA
US11767511B2 (en) 2018-11-30 2023-09-26 Cellphire, Inc. Platelets as delivery agents
SG11202112054WA (en) 2019-05-03 2021-11-29 Cellphire Inc Materials and methods for producing blood products
BR112022002892A2 (pt) 2019-08-16 2022-05-24 Cellphire Inc Trombossomos como um agente de reversão de agente antiplaqueta
WO2021158646A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Treatment of von willebrand disease
WO2021195496A2 (en) * 2020-03-27 2021-09-30 Platelet Biogenesis, Inc. Novel anucleated cells and uses thereof
IT202100021779A1 (it) 2021-08-11 2023-02-11 Plasfer S R L Piastrine trasfettate con sirna e loro usi terapeutici

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2296419T3 (es) * 1998-11-12 2008-04-16 Invitrogen Corporation Reactivos de transfeccion.

Also Published As

Publication number Publication date
ES2884727T3 (es) 2021-12-10
EP2951292B1 (en) 2021-05-26
WO2014118817A3 (en) 2014-10-09
US20150361453A1 (en) 2015-12-17
US20220411823A1 (en) 2022-12-29
EP2951292A2 (en) 2015-12-09
ITRM20130054A1 (it) 2014-07-31
PL2951292T3 (pl) 2021-12-13
WO2014118817A2 (en) 2014-08-07
US20230048730A1 (en) 2023-02-16
SI2951292T1 (sl) 2021-11-30
DK2951292T3 (da) 2021-08-23
HUE055345T2 (hu) 2021-11-29

Similar Documents

Publication Publication Date Title
HUE055345T2 (hu) Exogén genetikai anyaggal transzfektált vérlemezke és a transzfektált vérlemezekékkel nyert vérlemezke mikrorészecskék, eljárás azok elõállítására és alkalmazására
PL3659590T3 (pl) Kompozycja, materiały cząsteczkowe i sposoby wytwarzania materiałów cząsteczkowych
HK1215274A1 (zh) 包括光致變色-二向色性材料的光致變色製品
EP3188724A4 (en) Liposome encapsulated affinity drug
RS59796B1 (sr) Isparljiv materijal
EP2983231A4 (en) Composite material
GB201800246D0 (en) Vaporisable material
HK1216010A1 (zh) 控制藥物釋放的脂質體組合物
HK1221431A1 (zh) 微孔材料
GB2502241B (en) Packaging material and methods for manufacturing the same
EP3016688A4 (en) Radiolabelled material
SG11201705748SA (en) Anti-glycoprotein antibodies and uses thereof
GB2513479B (en) Damped composite material
EP2962562A4 (en) AQUEOUS SUSPENSION PESTICIDE COMPOSITION
GB201317293D0 (en) Methods, materials and products for delivering biocides
ZA201407558B (en) Itq-49 material, method for the production thereof and use of same
EP2980159A4 (en) POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIALS, OBTAINED OPTICAL MATERIAL AND METHOD FOR PRODUCING OPTICAL MATERIAL
GB2516047B8 (en) Material
PL2969988T3 (pl) Materiał ceramiczny
PT3233126T (pt) Nanopartículas para encapsular compostos, sua preparação e utilizações
EP2764926B8 (de) Textiler Materialstrang sowie Verfahren zu seiner Herstellung
EP2970916A4 (en) LEPIDOPTER INSECT CELLS SUITABLE FOR THE PRODUCTION OF RECOMBINANT PROTEINS
EP2986725A4 (en) METHOD AND MATERIALS FOR THE SECULATION OF PROTEINS
GB201308314D0 (en) Cast Material
EP3500601A4 (en) ENCAPSULATED MATERIALS WITH IMPROVED PROPERTIES